Cost analysis of capecitabine vs 5-fluorouracil-based treatment for metastatic colorectal cancer patients. [electronic resource]
Producer: 20100726Description: 125-8 p. digitalISSN:- 1973-9478
- Age Factors
- Antimetabolites, Antineoplastic -- economics
- Capecitabine
- Colorectal Neoplasms -- drug therapy
- Cost-Benefit Analysis
- Deoxycytidine -- analogs & derivatives
- Female
- Fluorouracil -- analogs & derivatives
- Health Expenditures
- Humans
- Longitudinal Studies
- Male
- Middle Aged
- Neoplasm Metastasis
- Retrospective Studies
- Sex Factors
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.